Advertisement
Advertisement

ACTU

ACTU logo

Actuate Therapeutics, Inc. Common stock

3.30
USD
Sponsored
-0.04
-1.20%
May 08, 15:57 UTC -4
Closed
exchange

After-Market

3.32

+0.02
+0.61%

Actuate Therapeutics, Inc. Common stock Profile

About

Actuate Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers. The company's lead product includes elraglusib. Actuate Therapeutics Inc. is based in FORT WORTH, Texas.

Info & Links

CEO

Daniel M. Schmitt

Headquarters

1751 RIVER RUN, SUITE 400
FORT WORTH, TX 76107, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://actuatetherapeutics.com/

Auditor

Crowe LLP

Share holders

--

Employees

12

Actuate Therapeutics, Inc. Common stock Statistics

Valuation Measures

Market Capitalization2

78.72M

Enterprise Value

65.56M

Enterprise Value/EBITDA(ttm)

-2.91

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.54

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-799.68%

Return on Invested Capital(ttm)

241.44%

Return on Assets(ttm)

-205.80%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-22.50M

Net Income Available to Common(ttm)

-22.23M

Diluted EPS(ttm)

-1.05

Share Statistics

Beta (5Y Monthly)

0.85

52-Week Change

-66.67%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

23.71M

Dividend Yield

0.00%

Float4

7.27M

% Held by Insiders

69.34%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

13.16M

Total Cash Per Share(mrq)

0.56

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.39%

Quick Ratio(mrq)

2.39%

Book Value Per Share(mrq)

0.34

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.91

Free Cash Flow(ytd)

-19.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement